CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 31  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0571
LYS 10.0208
GLU 20.0095
LEU 30.0029
ARG 40.0082
CYS 50.0071
GLN 60.0056
CYS 70.0136
ILE 80.0571
LYS 90.0420
THR 100.0251
TYR 110.0190
SER 120.0076
LYS 130.0134
PRO 140.0103
PHE 150.0206
HIS 160.0308
PRO 170.0148
LYS 180.0190
PHE 190.0106
ILE 200.0184
LYS 210.0283
GLU 220.0310
LEU 230.0218
ARG 240.0233
VAL 250.0249
ILE 260.0203
GLU 270.0200
SER 280.0133
GLY 290.0252
PRO 300.0233
HIS 310.0098
CYS 320.0046
ALA 330.0192
ASN 340.0051
THR 350.0123
GLU 360.0199
ILE 370.0246
ILE 380.0183
VAL 390.0194
LYS 400.0095
LEU 410.0136
SER 420.0270
ASP 430.0345
GLY 440.0312
ARG 450.0543
GLU 460.0195
LEU 470.0116
CYS 480.0207
LEU 490.0238
ASP 500.0234
PRO 510.0229
LYS 520.0068
GLU 530.0126
ASN 540.0443
TRP 550.0101
VAL 560.0067
GLN 570.0203
ARG 580.0186
VAL 590.0093
VAL 600.0081
GLU 610.0125
LYS 620.0116
PHE 630.0110
LEU 640.0090
LYS 650.0149
ARG 660.0123
ALA 670.0096
GLU 680.0183
ASN 690.0172

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.